D-[Ala2]endomorphin 2 and endomorphin 2 have nitric oxide-dependent vasodilator activity in rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 274, Issue 5 43-5, 1998, Pages

  Champion, Hunter C ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Naloxone sensitive mechanism; Nitric oxide release; Opioid receptor agonists; Regional vascular bed

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE RECEPTOR; DIETHYLAMINE; ENDORPHIN; ENDORPHIN DERIVATIVE; ISOPRENALINE; MECLOFENAMATE SODIUM; METENKEPHALIN; N (1 ADAMANTYL) N' CYCLOHEXYL 4 MORPHOLINECARBOXAMIDINE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; OPIATE RECEPTOR; ENDOMORPHIN 2; ENZYME INHIBITOR; MU OPIATE RECEPTOR; OLIGOPEPTIDE;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; HEART OUTPUT; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HEMODYNAMICS; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; VASODILATION;

EID: 0031805373     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.274.5.h1690     Document Type: Article

References (16)

1. 2-terminal 20 peptide in the rat. Peptides 18: 513-518, 1997.
2. 1 receptor, decreases cardiac output and total peripheral resistance in the rat. Peptides 18: 729-732, 1997.
3. Champion, H. C., J. E. Zadina, A. J. Kastin, L. Hackler, I.-J. Ge, and P. J. Kadowitz. Endomorphin 1 and 2, the endogenous μ-opioid agonists, have novel hypotensive activity in the rabbit. Biochem. Biophys. Res. Commun. 235: 567-570, 1997.
4. Devine, J. O., and W. M. Armstead. The role of nitric oxide in opioid-induced pial artery vasodilation. Brain Res. 675: 257-263, 1995.
5. Ferreira, S. H., I. D. Duarte, and B. B. Lorenzetti. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur. J. Pharmacol. 201: 121-122, 1991.
6. Feuerstein, G., and L. E. Siren. The opioid system in cardiac and vascular regulation of normal and hypertensive states. Circulation 75: 1125-1129, 1987.
7. Gyires, K. The role of endogenous nitric oxide in the gastroprotective action of morphine. Eur. J. Pharmacol. 255: 33-37, 1994.
8. Holaday, J. W. Cardiovascular effects of endogenous opiate systems. Ann. Rev. Pharmacol. 23: 541-549, 1983.
9. Johnson, M. W., W. E. Mitch, and C. S. Wilcox. The cardiovascular actions of morphine and the endogenous opioid peptides. Prog. Cardiovasc. Dis. 27: 435-450, 1985.
10. Koller, A., D. Sun, E. J. Messina, and G. Kaley. L-Arginine analogues blunt prostaglandin-related dilation of arterioles. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1194-H1199, 1993.
11. + channels. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H1498-H1506, 1996.
12. Liu, Y., D. Shenouda, T. V. Bilfinger, M. L. Stefano, H. I. Magazine, and G. B. Stefano. Morphine stimulates nitric oxide release from invertebrate microglia. Brain Res. 722: 125-131, 1996.
13. Majeed, N. H., B. Przewlocka, H. Machelska, and R. Przewloki. Inhibition of nitric oxide attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology 33: 189-192, 1994.
14. Parra, L., F. Perez-Vizcaino, A. Alsasua, M. I. Martin, and J. Tamargo. μ- and δ-Opioid receptor-mediated contractile effects of rat aorta vascular smooth muscle. Eur. J. Pharmacol. 277: 99-105, 1995.
15. 3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilation. J. Biol. Chem. 270: 30290-30293, 1995.
16. Zadina, J. E., L. Hackler, L.-J. Ge, and A. J. Kastin. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386: 499-502, 1997.